Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-07-03-Speech-2-596-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20120703.23.2-596-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Mr President, I would like to thank Mr Moreira for his question on this subject, because it could clarify and shed light on the situation.
We are dealing with a protocol to an agreement to align the legislative system of Israeli and EU infrastructure, but we need some clarifications and I would like to ask two questions. Firstly, are the Palestinian occupied territories part of the Israeli national market? Secondly, why is there not a human rights clause in this agreement?
With regard to product quality control and particularly in terms of the strict requirements concerning drugs, we are not against generic drugs. Quite the contrary, we think they are much more accessible, but we want guarantees. We want quality to be a requirement. Consequently, what certification is there going to be, and what knowledge are we going to have in Parliament regarding the quality certification of the drugs that are going to be produced in Israel?"@en1
|
lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples